These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7561036)

  • 1. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.
    Terada N; Takase K; Papst P; Nairn AC; Gelfand EW
    J Immunol; 1995 Oct; 155(7):3418-26. PubMed ID: 7561036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG; Shi Y; Mills GB; Miller RG
    Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2.
    Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB
    J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
    Dumont FJ; Fischer P; Sirotina A
    Exp Cell Res; 1995 Jul; 219(1):146-58. PubMed ID: 7543051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells.
    Lucas JJ; Terada N; Szepesi A; Gelfand EW
    J Immunol; 1992 Mar; 148(6):1804-11. PubMed ID: 1541821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
    J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L; Lipsky PE
    J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
    Dumont FJ; Kastner CA
    J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
    Algeciras-Schimnich A; Griffith TS; Lynch DH; Paya CV
    J Immunol; 1999 May; 162(9):5205-11. PubMed ID: 10227994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of the ribosomal gene during blast transformation of human lymphocytes].
    Kalousek I; Hlavácová M; Röselová P; Otevrelová P
    Cas Lek Cesk; 2002 Sep; 141 Suppl():54-7. PubMed ID: 12428425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
    Patel HR; Terada N; Gelfand EW
    Biochem Biophys Res Commun; 1996 Oct; 227(2):507-12. PubMed ID: 8878544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells.
    Ishizuka T; Sakata N; Johnson GL; Gelfand EW; Terada N
    Biochem Biophys Res Commun; 1997 Jan; 230(2):386-91. PubMed ID: 9016789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of the roles for iron and essential fatty acids in cell cycle progression of normal human T lymphocytes.
    Terada N; Or R; Szepesi A; Lucas JJ; Gelfand EW
    Exp Cell Res; 1993 Feb; 204(2):260-7. PubMed ID: 8440323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
    Dumont FJ; Staruch MJ; Grammer T; Blenis J; Kastner CA; Rupprecht KM
    Cell Immunol; 1995 Jun; 163(1):70-9. PubMed ID: 7538911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.